2 results
Approved WMOCompleted
Primary Objective* The primary objective of this study is to compare the confirmed objective response rate (ORR) by Week 19 following treatment with bevacizumab-Pfizer in combination with paclitaxel and carboplatin to bevacizumab-EU plus paclitaxel…
Approved WMOCompleted
Does melatonin by improving sleep parameters improve quality of life of hemodialysis patients?